Mayo Clinic

NCT07349771

Phase 2Withdrawn0 people20 Jan 2026clinicaltrials.gov

NCT07281547

Phase 4Not yet recruiting20 people15 Dec 2025clinicaltrials.gov

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Phase 4Recruiting40 people20 Oct 2025clinicaltrials.gov

NCT07213466

Phase 4Recruiting100 people9 Oct 2025clinicaltrials.gov

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

No phaseRecruiting170 people23 Sept 2025clinicaltrials.gov

NCT07171112

Phase 2Withdrawn0 people12 Sept 2025clinicaltrials.gov

NCT07139951

Phase 2Enrolling by invitation16 people24 Aug 2025clinicaltrials.gov

Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease

Early phase 1Recruiting30 people17 Jun 2025clinicaltrials.gov

Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

No phaseRecruiting150 people5 Jun 2025clinicaltrials.gov

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Phase 2Recruiting25 people30 May 2025clinicaltrials.gov

NCT06976619

Phase 2Recruiting60 people16 May 2025clinicaltrials.gov

NCT06940297

Phase 2Recruiting44 people23 Apr 2025clinicaltrials.gov

The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults

No phaseRecruiting300 people23 Apr 2025clinicaltrials.gov

A Randomized Controlled Trial of Menopausal Tool/App for Women

No phaseEnrolling by invitation900 people9 Apr 2025clinicaltrials.gov

NCT06905054

Phase 2Recruiting80 people1 Apr 2025clinicaltrials.gov

NCT06854406

Phase 1Completed8 people3 Mar 2025clinicaltrials.gov

NCT06814938

Phase 4Active, not recruiting135 people7 Feb 2025clinicaltrials.gov

NCT06803589

Early phase 1Recruiting10 people31 Jan 2025clinicaltrials.gov

NCT06801015

Phase 4Active, not recruiting30 people30 Jan 2025clinicaltrials.gov

NCT06785415

Phase 1/2Recruiting37 people21 Jan 2025clinicaltrials.gov